Evidence map›Paper›PMID 40815838›Full record

ArticleJMIR cancer2025

Implementation of Clinical Practice Guidelines to Prevent Cervical Cancer: Mixed Methods Study.

Oliver C Ezechi, Folahanmi T Akinsolu, Olunike R Abodunrin, Oluwabukola M Ola, Chisom Obi-Jeff, Ishak K Lawal, George U Eleje, Joseph D Tucker, Juliet I Iwelunmor

Abstract read
In one paragraph

Article in JMIR cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Oliver C EzechiNigerian Institute of Medical Research, Lagos, Nigeria.ORCID 0000-0003-0688-3898
Folahanmi T AkinsoluNigerian Institute of Medical Research, Lagos, Nigeria.ORCID 0000-0002-6782-9820
Olunike R AbodunrinNigerian Institute of Medical Research, Lagos, Nigeria.ORCID 0009-0001-5064-9444
Oluwabukola M OlaNigerian Institute of Medical Research, Lagos, Nigeria.ORCID 0009-0005-8766-2852
Chisom Obi-JeffBrooks Insight, Abuja, Nigeria.ORCID 0000-0003-1545-8754
Ishak K LawalFederal Medical Centre, Birnin-Kebbi, Kebbi, Nigeria.ORCID 0000-0002-7594-7026
George U ElejeNnamdi Azikiwe University Teaching Hospital Nnewi, Anambra, Nigeria.ORCID 0000-0002-0390-2152
Joseph D TuckerUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, United States.ORCID 0000-0003-2804-1181
Juliet I IwelunmorWashington University School of Medicine, St Louis, MO, United States.ORCID 0000-0003-1376-5443

Funding

US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)U54CA284110 · NCI · WASHINGTON UNIVERSITY · PI OLIVER CHUKWUJEKWU EZECHI, Juliet Iwelunmor · 2023 to 2026
$5.0M
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV)R01CA271033 · NCI · WASHINGTON UNIVERSITY · PI OLIVER CHUKWUJEKWU EZECHI, Juliet Iwelunmor · 2022 to 2026
$2.5M
Syphilis social epidemiology in the People's Republic of ChinaK01TW008200 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TUCKER, JOSEPH DAVID · 2010 to 2013
$527k
FIC NIH HHS K01 TW008200NCI NIH HHS R01 CA271033NCI NIH HHS U54 CA284110
6 · The paper itself

Abstract

backgroundCervical cancer is a common cause of death among women globally, particularly in Africa. Each year, an average of 7093 women in Nigeria die from cervical cancer. Clinical practice guidelines developed by the Society of Obstetrics and Gynecology of Nigeria (SOGON) aim to prevent cervical cancer. However, the extent of their adoption among gynecologists remains unclear.

objectiveThis study aimed to assess Nigerian gynecologists' awareness, understanding, and incorporation of the SOGON clinical practice guidelines for cervical cancer prevention in their clinical practices.

methodsA convergent parallel mixed methods design was used. Quantitative data were collected via a web-based and in-person survey distributed to gynecologists attending the 57th SOGON Annual General Meeting in Kano, Nigeria (November 2023). A total of 105 gynecologists completed the survey (response rate: 80%). Key informant interviews (n=12) were conducted to provide qualitative insights. Quantitative data were analyzed using descriptive and inferential statistics, including logistic regression (P<.05). Thematic analysis was applied to qualitative data.

resultsAmong the 105 respondents (mean age 50, SD 8.3 y and mean postresidency practice 12, SD 9.4 y), 98 (93.3%) reported awareness of the SOGON guidelines, and 74 (70.5%) endorsed their importance for cervical cancer prevention. However, only 58.1% (61/105) of the respondents reported integrating the guidelines into routine clinical practice. Barriers to implementation included limited training (71/105, 67.6%), resource constraints (64/105, 60.9%), and lack of institutional support (57/105, 54.3%). Qualitative data reinforced the need for more tailored guidelines for high-risk populations and rural settings. In addition, 70.5% (74/105) of the respondents advocated for a participatory guideline review process to ensure relevance and feasibility.

conclusionsWhile awareness of the SOGON guidelines is high, their integration into clinical practice remains suboptimal due to systemic barriers. Strengthening training programs, improving access to resources, and enhancing institutional support are critical to increasing guideline adoption and advancing cervical cancer prevention efforts in Nigeria.

Indexed as

Guideline AdherenceGynecologyPractice Guidelines as TopicPractice Patterns, Physicians'Uterine Cervical NeoplasmsAdultFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedNigeriaSurveys and Questionnairescervical cancer preventionclinical practice guidelinesgynecologistsimplementation scienceNigeria

Identifiers

PMID40815838
PMCPMC12904100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.